Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis

Biological Psychiatry

Volumn 58, Issue 5, 2005, Pages 417-423

  Garner, Belinda ^a,d   Pariante, Carmine M ^b   Wood, Stephen J ^a   Velakoulis, Dennis ^a   Phillips, Lisa ^a,c   Soulsby, Bridget ^a   Brewer, Warrick J ^c   Smith, Deidre J ^c   Dazzan, Paola ^b   Berger, Gregor E ^a,c   Yung, Alison R ^a,c   Van Den Buuse, Maarten ^d   Murray, Robin ^b   McGorry, Patrick D ^a,c   Pantelis, Christos ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c ORYGEN RESEARCH CENTRE   (Australia)

^d FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

High risk; Hypothalamic pituitary adrenal axis; Pituitary; Psychosis; Schizophrenia

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HYPOPHYSIS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PITUITARY VOLUME; PREDICTION; PRIORITY JOURNAL; PSYCHOSIS; REGRESSION ANALYSIS; SURVIVAL;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PITUITARY GLAND; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RISK; SCHIZOPHRENIC PSYCHOLOGY; SURVIVAL RATE; TIME FACTORS;

EID: 24044452847     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2005.04.018     Document Type: Article

References (58)

1. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 4th ed 1994 American Psychiatric Press Washington, DC
2. N.C. Andreasen The Scale for the Assessment of Negative Symptoms (SANS) Conceptual and theoretical foundations Br J Psychiatry Suppl 7 1989 49 58
3. D.A. Axelson, P.M. Doraiswamy, O.B. Boyko, E.P. Rodrigo, W.M. McDonald, J.C. Ritchie In vivo assessment of pituitary volume with magnetic resonance imaging and systematic stereology Relationship to dexamethasone suppression test results in patients Psychiatry Res 44 1992 63 70
4. P. Bebbington, S. Wilkins, P. Jones, A. Foerster, R. Murray, B. Toone Life events and psychosis. Initial results from the Camberwell Collaborative Psychosis Study Br J Psychiatry 162 1993 72 79
5. N. Bergemann, C. Mundt, P. Parzer, I. Jannakos, I. Nagl, B. Salbach Plasma concentrations of estradiol in women suffering from schizophrenia treated with conventional versus atypical antipsychotics Schizophr Res 73 2005 357 366
6. W. Brewer, S. Wood, H. Jackson, C. Pantelis, A.R. Yung, P.D. McGorry Memory impairments in people at ultra high-risk for psychosis who later develop first-episode psychosis Am J Psychiatry 162 2005 71 78
7. D. Cotter, C.M. Pariante Stress and the progression of the developmental hypothesis of schizophrenia Br J Psychiatry 181 2002 363 365
8. P.M. Doraiswamy, K.R. Krishnan, G.S. Figiel, M.M. Husain, O.B. Boyko, W.J. Rockwell A brain magnetic resonance imaging study of pituitary gland morphology in anorexia nervosa and bulimia Biol Psychiatry 28 1990 110 116
9. A.D. Elster Modern imaging of the pituitary Radiology 187 1993 1 14
10. A.D. Elster, M.Y. Chen, D.W. Williams III, L.L. Key Pituitary gland MR imaging of physiologic hypertrophy in adolescence Radiology 174 1990 681 685
11. J. Eritaia, S.J. Wood, G.W. Stuart, N. Bridle, P. Dudgeon, P. Maruff An optimized method for estimating intracranial volume from magnetic resonance images Magn Reson Med 44 2000 973 977
12. M. First, R. Spitzer, M. Gibbon, J. Williams Structured Clinical Interview for DSM-IV Axis I Disorders 1997 American Psychiatric Association Washington, DC
13. P. Gallagher, S. Watson, M.S. Smith, I.N. Ferrier, A.H. Young Effects of adjunctive mifepristone (RU-486) administration on neurocognitive function and symptoms in schizophrenia Biol Psychiatry 57 2005 155 161
14. M. Hamilton The assessment of anxiety states by rating Br J Med Psychol 32 1959 50 55
15. M. Hamilton A rating scale for depression J Neurol Neurosurg Psychiatry 23 1960 56 62
16. M.I. Herz, G.A. Fava, G. Molnar, L. Edwards The dexamethasone suppression test in newly hospitalized schizophrenic patients Am J Psychiatry 142 1985 127 129
17. T.J. Huber, J. Rollnik, J. Wilhelms, A. von zur Muhen, H.M. Emrich, U. Schneider Estradiol levels in psychotic disorders Psychoneuroendocrinology 26 2001 27 35
18. K.R. Krishnan, P.M. Doraiswamy, S.N. Lurie, G.S. Figiel, M.M. Husain, O.B. Boyko Pituitary size in depression J Clin Endocrinol Metab 72 1991 256 259
19. C.H. Lammers, D. Garcia-Borreguero, J. Schmider, U. Gotthardt, M. Dettling, F. Holsboer Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls II Biol Psychiatry 38 1995 803 807
20. C. Lum, W. Kucharczyk, W. Montanera, L. Becker The sella turcica and parasellar region S.W. Atlas Magnetic Resonance Imaging of the Brain and Spine 3rd ed. 2002 Lippincott Willimas & Wilkins Philadelphia 1283 1362
21. F.P. MacMaster, V. Kusumakar MRI study of the pituitary gland in adolescent depression J Psychiatr Res 38 2004 231 236
22. C.M. Mazure, D.M. Quinlan, M.B. Bowers Jr Recent life stressors and biological markers in newly admitted psychotic patients Biol Psychiatry 41 1997 865 870
23. P.D. McGorry, A.R. Yung, L.J. Phillips The "close-in" or ultra high-risk model A safe and effective strategy for research and clinical intervention in prepsychotic mental disorder Schizophr Bull 29 2003 771 790
24. P.D. McGorry, A.R. Yung, L.J. Phillips, H.P. Yuen, S. Francey, E.M. Cosgrave Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms Arch Gen Psychiatry 59 2002 921 928
25. K. Mineura, T. Goto, M. Yoneya, M. Kowada, Y. Tamakawa, H. Kagaya Pituitary enlargement associated with Addison's disease Clin Radiol 38 1987 435 437
26. D. Muck-Seler, N. Pivac, M. Mustapic, Z. Crncevic, M. Jakovljevic, M. Sagud Platelet serotonin and plasma prolactin and cortisol in healthy, depressed and schizophrenic women Psychiatry Res 127 2004 217 226
27. I. Myin-Germeys, J. van Os, J.E. Schwartz, A.A. Stone, P.A. Delespaul Emotional reactivity to daily life stress in psychosis Arch Gen Psychiatry 58 2001 1137 1144
28. C.B. Nemeroff The corticotropin-releasing factor (CRF) hypothesis of depression New findings and new directions Mol Psychiatry 1 1996 336 342
29. C. Pantelis, D. Velakoulis, P.D. McGorry, S.J. Wood, J. Suckling, L.J. Phillips Neuroanatomical abnormalities before and after onset of psychosis A cross-sectional and longitudinal MRI comparison Lancet 361 2003 281 288
30. C.M. Pariante Depression, stress and the adrenal axis J Neuroendocrinol 15 2003 811 812
31. Pariante CM, Dazzan P, Danese A, Morgan KD, Brudaglio F, Morgan C, et al (in press): Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the Æsop First-Onset Psychosis Study. Neuropsychopharmacology.
32. C.M. Pariante, A.H. Miller Glucocorticoid receptors in major depression Relevance to pathophysiology and treatment Biol Psychiatry 49 2001 391 404
33. C.M. Pariante, A.S. Papadopoulos, L. Poon, S.A. Checkley, J. English, R.W. Kerwin A novel prednisolone suppression test for the hypothalamic- pituitary- adrenal axis Biol Psychiatry 51 2002 922 930
34. C.M. Pariante, K. Vassilopoulou, D. Velakoulis, L. Phillips, B. Soulsby, S.J. Wood Pituitary volume in psychosis Br J Psychiatry 185 2004 5 10
35. L. Phillips, A.R. Yung, N. Hearn, C. McFarlane, M. Hallgren, P.D. McGorry Preventative mental health care Accessing the target population Aust N Z J Psychiatry 33 1999 912 917
36. L.J. Phillips, D. Velakoulis, C. Pantelis, S. Wood, H.P. Yuen, A.R. Yung Non-reduction in hippocampal volume is associated with higher risk of psychosis Schizophr Res 58 2002 145 158
37. L.J. Phillips, A.R. Yung, P.D. McGorry Identification of young people at risk of psychosis Validation of Personal Assessment and Crisis Evaluation Clinic intake criteria Aust N Z J Psychiatry 34 suppl 2000 S164 S169
38. L.J. Phillips, A.R. Yung, H.P. Yuen, C. Pantelis, P.D. McGorry Prediction and prevention of transition to psychosis in young people at incipient risk for schizophrenia Am J Med Genet 114 2002 929 937
39. C.L. Raison, A.H. Miller When not enough is too much The role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders Am J Psychiatry 160 2003 1554 1565
40. H.M. Rhoades, J.E. Overall The semistructured BPRS interview and rating guide Psychopharmacol Bull 24 1988 101 104
41. M.C. Ryan, P. Collins, J.H. Thakore Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia Am J Psychiatry 160 2003 284 289
42. M.C. Ryan, N. Sharifi, R. Condren, J.H. Thakore Evidence of basal pituitary-adrenal overactivity in first episode, drug naive patients with schizophrenia Psychoneuroendocrinology 29 2004 1065 1070
43. E.J. Sachar, S.S. Kanter, D. Buie, R. Engle, R. Mehlman Psychoendocrinology of ego disintegration Am J Psychiatry 126 1970 1067 1078
44. R.B. Sassi, M. Nicoletti, P. Brambilla, K. Harenski, A.G. Mallinger, E. Frank Decreased pituitary volume in patients with bipolar disorder Biol Psychiatry 50 2001 271 280
45. A.F. Schatzberg New approaches to managing psychotic depression J Clin Psychiatry 64 suppl 1 2003 19 23
46. M. Segal, A. Avital, M. Rojas, N. Hausvater, S. Sandbank, D. Liba Serum prolactin levels in unmedicated first-episode and recurrent schizophrenia patients A possible marker for the disease's subtypes Psychiatry Res 127 2004 227 235
47. R. Tandon, C. Mazzara, J. DeQuardo, K.A. Craig, J.H. Meador-Woodruff, R. Goldman Dexamethasone suppression test in schizophrenia Relationship to symptomatology, ventricular enlargement, and outcome Biol Psychiatry 29 1991 953 964
48. D. Velakoulis, C. Pantelis, P.D. McGorry, P. Dudgeon, W. Brewer, M. Cook Hippocampal volume in first-episode psychoses and chronic schizophrenia A high-resolution magnetic resonance imaging study Arch Gen Psychiatry 56 1999 133 141
49. D.J. Walder, E.F. Walker, R.J. Lewine Cognitive functioning, cortisol release, and symptom severity in patients with schizophrenia Biol Psychiatry 48 2000 1121 1132
50. E.F. Walker, D. Diforio Schizophrenia A neural diathesis-stress model Psychol Rev 104 1997 667 685
51. E.F. Walker, D.J. Walder, F. Reynolds Developmental changes in cortisol secretion in normal and at-risk youth Dev Psychopathol 13 2001 721 732
52. M.D. Warner, A.M. Walker, D.C. D'Souza, D. Lee, D. Nasseri, C.A. Peabody Lower prolactin bioactivity in unmedicated schizophrenic patients Psychiatry Res 102 2001 249 254
53. D.D. Weinstein, D. Diforio, J. Schiffman, E. Walker, R. Bonsall Minor physical anomalies, dermatoglyphic asymmetries, and cortisol levels in adolescents with schizotypal personality disorder Am J Psychiatry 156 1999 617 623
54. S.J. Wood, C. Pantelis, T. Proffitt, L.J. Phillips, G.W. Stuart, J.A. Buchanan Spatial working memory ability is a marker of risk-for-psychosis Psychol Med 33 2003 1239 1247
55. A.H. Young, P. Gallagher, S. Watson, D. Del Estal, B.M. Owen, I. Nicol Ferrier Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder Neuropsychopharmacology 29 2004 1538 1545
56. M. Yucel, S. Wood, L.J. Phillips, G.W. Stuart, D.J. Smith, A.R. Yung Morphology of the anterior cingulate cortex in young men at ultra-high risk of developing a psychotic illness Br J Psychiatry 182 2003 518 524
57. A.R. Yung, L.J. Phillips, H.P. Yuen, S.M. Francey, C.A. McFarlane, M. Hallgren Psychosis prediction 12-month follow up of a high-risk ("prodromal") group Schizophr Res 60 2003 21 32
58. A.R. Yung, L.J. Phillips, H.P. Yuen, P.D. McGorry Risk factors for psychosis in an ultra high-risk group Psychopathology and clinical features Schizophr Res 67 2004 131 142